Venous endothelial cells (VEC) (VEC)

Venous endothelial cells (VECs) are the specialized cells that line the interior surface of veins, forming a critical interface between circulating blood and the vessel wall (Aird, 2007). They are physiologically distinct from arterial endothelial cells, characterized by their adaptation to low-pressure and low-shear stress environments and the expression of specific markers such as the receptor tyrosine kinase EphB4 and the transcription factor COUP-TFII (Wang et al., 1998; You et al., 2005). VECs are essential for maintaining vascular homeostasis, regulating blood flow, and managing the recruitment of immune cells through the expression of adhesion molecules (StatPearls, 2023). Furthermore, VECs are involved in the regulation of fluid balance and the transport of solutes, making them vital for tissue health and the prevention of edema (Aird, 2007). In disease states, VEC dysfunction is a primary driver of venous thromboembolism, chronic venous insufficiency, and the formation of varicose veins (PubMed, 2021). Although VECs are a cell type rather than a single molecular target, they are the focus of therapies aimed at modulating coagulation, inflammation, and angiogenesis, with drugs often targeting specific receptors or enzymes expressed on their surface (NIH, 2022).

Other names

Venous endotheliumVascular endothelial cells (venous)VEC

Pharmacological agents interact with specific molecular components of venous endothelial cells, such as surface receptors (e.g., VEGFR), adhesion molecules (e.g., VCAM-1), or intracellular signaling pathways, to regulate thrombosis, inflammation, and vessel permeability (Aird, 2007; NIH, 2022).